Skip to main content

Second COVID-19 Vaccine Booster Dose Update

Last updated on

On March 29, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech and Moderna COVID-19 vaccines as follows:

  • Authorization for individuals 50 years or older of a second booster dose, if at least 4 months after the first booster dose, of any authorized or approved COVID-19 vaccine.
  • Authorization for immunocompromised individuals of a second booster dose, if at least 4 months after the first booster dose, of any authorized or approved COVID-19 vaccine, subject to the following age-specific limitations for particular vaccines:
    • The Pfizer-BioNTech COVID-19 vaccine is indicated for individuals 12 years or older.
    • The Moderna COVID-19 vaccine is indicated for individuals 18 years or older.

The Texas Health and Human Services Commission allows for pharmacy benefit coverage of the Pfizer-BioNTech and Moderna COVID-19 vaccines in compliance with the expanded use authorized by the FDA.

Details are available on the Texas Medicaid & Healthcare Partnership (TMHP) website at www.tmhp.com.

Contact vdp-formulary@hhsc.state.tx.us with any comments or questions.